skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Adherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience

Original Research

(2419) Views  (536) Full article downloads

Authors: Tatiana de Melo Gomes de Oliveira, Ana Patricia Peres Fiore, Yára Dadalti Fragoso

Published Date March 2008 Volume 2008:2 Pages 41 - 46
DOI: http://dx.doi.org/10.2147/PPA.S2255

Tatiana de Melo Gomes de Oliveira1, Ana Patricia Peres Fiore2, Yára Dadalti Fragoso2

1TEVA Pharmaceutical, Brazil; 2Medical School of Universidade Metropolitana de Santos and Reference Center for Multiple Sclerosis of the coastal region of the State of São Paulo (DRS-IV), Brazil

Abstract: Multiple sclerosis is a chronic disease characterized by demyelination and neurodegeneration of the central nervous system. Immunomodulatory treatment is possible at an early stage of the disease, and consists of injections of either beta-interferon or glatiramer acetate. The drugs are not curative, and the need for frequent injections may give rise to a serious problem regarding adherence to treatment. The present study analyzed the database of all Brazilian patients using glatiramer acetate between June 2003 and December 2006 who had enrolled in the patient program run by the pharmaceutical company commercializing the drug. The rate of treatment discontinuation was 10% over this period, and the main reason for suspending the drug was medical decisions (47% of all discontinuations), rather than side effects or the patient’s choice. The present work did not take into consideration the regularity of injections and the main objective was to assess discontinuation. It was concluded that adequate healthcare, education, and a specific program for patients were the factors responsible for this 90% adherence to glatiramer acetate treatment in Brazil.

Keywords: multiple sclerosis, glatiramer acetate, adherence








Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Health-related quality of life assessment in people with multiple sclerosis and their family caregivers. A multicenter study in Catalonia (Southern Europe)
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Primary care for diabetes mellitus: perspective from older patients